391 related articles for article (PubMed ID: 7796119)
1. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies.
Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL
Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.
Klette KL; Lin Y; Clapp LE; DeCoster MA; Moreton JE; Tortella FC
Brain Res; 1997 May; 756(1-2):231-40. PubMed ID: 9187337
[TBL] [Abstract][Full Text] [Related]
3. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures.
Shimazu S; Katsuki H; Takenaka C; Tomita M; Kume T; Kaneko S; Akaike A
Eur J Pharmacol; 2000 Jan; 388(2):139-46. PubMed ID: 10666505
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
5. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I
Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251
[TBL] [Abstract][Full Text] [Related]
6. Involvement of direct inhibition of NMDA receptors in the effects of sigma-receptor ligands on glutamate neurotoxicity in vitro.
Nishikawa H; Hashino A; Kume T; Katsuki H; Kaneko S; Akaike A
Eur J Pharmacol; 2000 Sep; 404(1-2):41-8. PubMed ID: 10980261
[TBL] [Abstract][Full Text] [Related]
7. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
Nakazawa M; Matsuno K; Mita S
Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556
[TBL] [Abstract][Full Text] [Related]
8. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
10. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
[TBL] [Abstract][Full Text] [Related]
12. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
[TBL] [Abstract][Full Text] [Related]
13. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro.
Kume T; Nishikawa H; Taguchi R; Hashino A; Katsuki H; Kaneko S; Minami M; Satoh M; Akaike A
Eur J Pharmacol; 2002 Nov; 455(2-3):91-100. PubMed ID: 12445574
[TBL] [Abstract][Full Text] [Related]
15. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Larson AA; Sun X
Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies.
Graham D; Darles G; Langer SZ
Eur J Pharmacol; 1992 Aug; 226(4):373-6. PubMed ID: 1356814
[TBL] [Abstract][Full Text] [Related]
18. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site.
Yamamoto H; Yamamoto T; Sagi N; Klenerová V; Goji K; Kawai N; Baba A; Takamori E; Moroji T
J Neurosci; 1995 Jan; 15(1 Pt 2):731-6. PubMed ID: 7529831
[TBL] [Abstract][Full Text] [Related]
19. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
Monnet FP; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Apr; 261(1):123-30. PubMed ID: 1532832
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
